| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |